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Abstract
Background: Cutaneous leishmaniasis can be caused by several Leishmania species and is
transmitted to human beings and animals by sand flies, Down syndrome is known to cause
immunodeficiency that might lead to increase the susceptibility to infection with Leishmania.
Up to our knowledge this is the first case of isolated facial cutaneous leshmaniasis in association
with Down syndrome.
Case presentation: A 2 month old Saudi Arabian male infant was admitted in the pediatric ward
of maternity and children's hospital, Buraidah, Kingdom of Saudi Arabia for the management of
multiple ulcers on his face, two ulcers were big and were surrounded by edema, causing severe
disfigurement. This disfigurement caused difficulty in recognizing the facial feature of Down
syndrome. The presence of hypotonia, microcephaly, low set ears, bilateral simian creases and wide
separation between big toe and other toes directed us to request karyotyping. The result of
karyotyping confirmed the diagnosis of Down syndrome.
Conclusion: Children with Down syndrome are immunodeficient, they have been reported to
have a complex of immunological alterations which might lead to increased susceptibility to
infection.
Background
Leishmaniasis consists of a group of diverse diseases that
affect viscera, skin, and/or mucous membranes with a
wide spectrum of clinical activity caused by vector-borne,
obligate, intracellular hemoflagellates of the genus leish-
mania. Three major clinical syndromes are recognized:
visceral, cutaneous, and mucocutaneous leishmaniasis.
The clinical manifestations of leishmaniasis appear to
depend on a complex set of factors, including tropism and
virulence of the parasite strain and the susceptibility of the
host that may be genetically determined [1].
The true incidence of leishmaniasis is not known. How-
ever, the World Health Organization (WHO) has esti-
mated that 350 million individuals are at risk and that the
disease is endemic in more than 80 countries. The esti-
mated incidence of visceral leishmaniasis is 500,000 cases
per year, and for cutaneous leishmaniasis and mucocuta-
neous leishmaniasis, it is 1.5 million cases per year.
Although the parasite most commonly is transmitted via
the bite of the sand fly vector, it may be transmitted also
as a result of a laboratory accident, direct person-to-per-
son transmission, and blood transfusion. In addition,
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Cutaneous leishmaniasis can be caused by several Leish-
mania species and is transmitted to human beings and
animals by sand flies. In endemic countries, diagnosis is
often made clinically and, if possible, by microscopic
examination of lesion biopsy smears to visually confirm
leishmania parasites as the cause. The use of more sophis-
ticated diagnostic techniques that allow for species identi-
fication is usually restricted to research or clinical settings
in non-endemic countries. The mainstays of cutaneous
leishmaniasis treatment are pentavalent antimonials,
with new oral and topical treatment alternatives only
becoming available within the past few years; a vaccine
currently does not exist. Disease prevention and control
are difficult because of the complexity of cutaneous leish-
maniasis epizoology, and the few options available [2].
Case presentation
A two months old Saudi Arabian male infant was admit-
ted to the pediatric ward of maternity and children's hos-
pital, Buraidah, Kingdom of Saudi Arabia for the
management of multiple ulcers on his face. The ulcers was
observed by the parents at the age of one month and pro-
gressively increased in size with no history of fever. He
was the third child of healthy unrelated boduin Saudi Ara-
bian parents, the mother's age was 35 and the father's age
was 40. There was no history of perinatal or postnatal
complication. The child was delivered in a tent in the
desert where his parents live.
On physical examination, there was severe disfigurement
of the face with 3 crusty ulcers Surrounded by a notable
erythematous reaction, the biggest one presents on the
right cheek and measures 2 × 2 cm. The second ulcer
presents on the right lower eye lid and measures 1 × 1.5
cm. The third ulcer presents on the forehead and measures
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lymphadenphathy or hepatosplenomegaly.
On first look to the face of our case, it was difficult to rec-
ognize the facial features of Down syndrome because of
severe disfigurement of the face, the ulcers were sur-
rounded by extensive edema that caused the eyes to be
closed most of the times so the upslanting palpebral fis-
sures which is a very characteristic feature of Down syn-
drome was not so obvious, in addition the presence of an
ulcer near the nasal bridge added more difficulty to recog-
nize the facial features but the presence of hypotonia, flat
occiput, short neck, low set ears, short broad hands; clin-
odactyly of fifth finger; bilateral simian creases of the
hands and gap between the first and second toes, directed
us to request karyotyping. The result of karyotyping con-
firmed our suspicion and the diagnosis of Down syn-
drome was confirmed.
Blood count and immunological study were normal
except for the presence of lymphopenia and inverted
CD4/CD8 ratio. The baseline erythrocyte sedimentation
rate was normal. Liver, kidney, and thyroid function tests
(TSH, T3, and T4) were within normal limits. Histopatho-
logic examination of the ulcers' sections stained with
hematoxylin and eosin showed a superficial reticular der-
mis occupied by large pale histiocytes with leishmania.
With the Giemsa stain technique multiple leishmania
were seen confirming the diagnosis of cutaneous leishma-
niasis. After the diagnosis of leishmaniasis, sodium anti-
mony gluconat was administered intravenously along
with other antibiotics, the condition started to improve
but unfortunately after two weeks of treatment the child
was discharged from the hospital under the request and
insistence of his parents. The parents were seeking cautery
treatment for the ulcers which is a common practice in the
Kingdom of Saudi Arabia; the parents refused all medical
advices to continue the treatment in the hospital. The
child was discharged and was never seen again.
Discussion
Up to our knowledge this is the first case of isolated facial
Cutanenous leshmaniasis affecting the face of a Down
syndrome infant. The age of our case is the youngest age
affected with cutaneous leishmaniasis in literature.
Ferreli et al reported an atypical leishmaniasis involving
the inferior lip of a 57-year-old female with Down's syn-
drome at the Dermatology Department of Cagliari (Italy)
[3].
Children with Down syndrome are immunodeficient [4],
they have been reported to have a complex of immuno-
logical alterations, supposedly associated with a greatly
enhanced susceptibility to infections [5]. Among these
immunological changes, a low number of circulating B
cells [6], decrease of CD4+ and increase of CD8+ cells
with an inverted CD4/CD8 ratio [7], and increased per-
centage of cells bearing markers associated with NK activ-
ity [8] are now well established. Susceptibility to
cutaneous leishmaniasis can be greatly influenced by mal-
nutrition [9], immunosuppression (e.g. HIV) [10], host
genetic background [11] and less frequently in those who
have undergone organ transplant, chemotherapy for
malignancy or suffer from immune-mediated disorders.
Leishmania and HIV coinfections have been reported in
35 out of the 88 countries in which leishmaniasis is
endemic [12].
Cell-mediated immunity appears to be a major factor
modulating leishmania infection [13]. Lymphopenia and
inverted CD4/CD8 ratio were observed in our case and
this can explain the extensive and huge ulcers and affec-
tion in the early infancy.
Although cutaneous leishmaniasis does not cause mortal-
ity, the cosmetic disfiguration, prolonged period of
lesions, great expense of treatment, and side effects of
available drugs, it has created many problems [14]. In our
case one of the ulcers was located near to lower eye lid,
contiguous spread may extend to the conjunctiva, epis-
clera, and cornea, with development of interstitial kerati-
tis, therefore, ocular leishmaniasis is considered
potentially a blinding disorder [15].
Previous descriptions of the disease indicated that extrem-
ities were more often involved in cutaneous leishmaniasis
than the face [16,17]. This finding may be explained by
the fact that sand flies usually travel close to the ground
where they can easily bite the lower extremities. In addi-
tion, sleeping outdoors and the exposure of extremities
may encourage sand flies to bite during the night [16]. In
our case in addition to sleeping outdoors in the desert and
inside tent on ground, the culture traditions in Kingdom
of Saudi Arabia is to keep the whole infant's body covered
except his face, this can explain why the face is only
affected in our case.
The presence of multiple skin lesions on the face of our
case may be attributed to the fact that a sand fly, because
of its physiologic characteristics, bites the host more than
one time, and from every area of the bite, parasites enter
the blood [18].
Conclusion
Children with Down syndrome are immunodeficient,
they have been reported to have a complex of immuno-
logical alterations which might lead to increased suscepti-
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